Vaxcell Bio Therapeutics
KOSDAQ:323990
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vaxcell Bio Therapeutics
KOSDAQ:323990
|
KR |
|
Trivago NV
NASDAQ:TRVG
|
DE |
|
C
|
Cardinal Health Inc
F:CLH
|
US |
|
I
|
Indofood Sukses Makmur Tbk PT
F:ISM
|
ID |
|
Teleperformance SE
F:RCF
|
FR |
|
N
|
Netcall PLC
F:NEW
|
UK |
|
Markel Corp
NYSE:MKL
|
US |
|
Daqin Railway Co Ltd
SSE:601006
|
CN |
|
A
|
Airport City Ltd
TASE:ARPT
|
IL |
|
S
|
Soracom Inc
TSE:147A
|
JP |
|
M
|
MB Securities JSC
VN:MBS
|
VN |
|
ASML Holding NV
MIL:1ASML
|
NL |
|
P
|
Pulsar Group PLC
LSE:PULS
|
UK |
|
B
|
Briacell Therapeutics Corp
NASDAQ:BCTX
|
CA |
|
PLDT Inc
XPHS:TEL
|
PH |
|
A
|
Advantest Corp
SWB:VAN
|
JP |
|
Emetals Ltd
ASX:EMT
|
AU |
|
Trustmark Corp
NASDAQ:TRMK
|
US |
|
M
|
Murata Manufacturing Co Ltd
OTC:MRAAF
|
JP |
|
Minerals Technologies Inc
NYSE:MTX
|
US |
|
A
|
Alexander's Inc
SWB:AXE
|
US |
|
F
|
Fanuc Corp
SWB:FUC
|
JP |
|
Dentsu Group Inc
TSE:4324
|
JP |
|
O
|
Ormat Technologies Inc
F:HNM
|
US |
Bankruptcy Probability
Vaxcell Bio Therapeutics's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Vaxcell Bio Therapeutics Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
V
|
Vaxcell Bio Therapeutics
KOSDAQ:323990
|
99.9B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
466.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
205.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
187.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
63.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84.1B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
52.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Vaxcell Bio Therapeutics's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Vaxcell Bio Therapeutics has total debt of 1.1B KRW. This includes both short-term (0 KRW) and long-term (1.1B KRW) debt.
You can find a full breakdown on its Balance Sheet.